Skip to main content English

Publikationen

  • Bsteh G., Macher S., Krajnc N., Pruckner P., Marik W., Mitsch C., Novak K., Pemp B., Wöber C. Idiopathic intracranial hypertension presenting with migraine phenotype is associated with unfavorable headache outcomes. Headache J Head Face Pain (2023) doi:10.1111/head.14478.
  • Krajnc N., Itariu B., Macher S., Marik W., Harreiter J., Michl M., Novak K., Wöber C., Pemp B., Bsteh G. Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension. J. Headache Pain 24, 89 (2023).
  • Pruckner P., Mitsch C., Macher S., Krajnc N., Marik W., Novak K., Wöber C., Pemp B., Bsteh G. The Vienna idiopathic intracranial hypertension database—An Austrian registry. Wien. Klin. Wochenschr. 1–8 (2023) doi:10.1007/s00508-023-02252-x.
  • Bsteh G., Marik W., Krajnc N., Macher S., Mitsch C., Pruckner P., Novak K., Wöber C., Pemp B. MRI features of idiopathic intracranial hypertension are not prognostic of visual and headache outcome. J. Headache Pain 24, 97 (2023).
  • Bsteh G., Marik W., Macher S., Schmidbauer V., Krajnc N., Pruckner P., Mitsch C., Novak K., Wöber C., Pemp B. Impact of rater experience and referral question on detecting MRI features of idiopathic intracranial hypertension. Eur. J. Neurol. (2023) doi:10.1111/ene.15986.